Brief: Somnomed says FY24 Guidance Remains Unchanged

SomnoMed

29/10/2023 23:31

Oct 30 (Reuters) - Somnomed Ltd  SOM.AX :
    * FY24 GUIDANCE REMAINS UNCHANGED
    * Q1 FY24 REVENUE OF A$21.4 MILLION UP 15.2% VERSUS PCP

Source text for Eikon:  ID:nASX1hM4Jv 
Further company coverage:  SOM.AX 

 ((Reuters.Briefs@thomsonreuters.com;;))